Answers are grounded in this paper and cite their sources.
Lichen symbioses are among the most successful mutualisms in extreme environments, yet the biochemical traits that enable algal partners to thrive within them remain poorly defined. We used untargeted GC-MS to uncover metabolic rules underlying symbiotic compatibility. Comparing 21 Trebouxiophyceae species, including free-living microalgae and lichen photobionts, we identified 260 metabolites, concluding that sugar alcohol metabolism emerged as the principal axis of differentiation, with ribitol-rich taxa consistently dominating lichen partnerships. High ribitol producers shared a coordinated metabolic program coupling elevated malate with compatible solutes (glycerol, inositol, proline) and phospholipid intermediates, supporting osmoprotection, redox balance, and membrane remodeling. They released ribitol into the culture medium together with a distinctive suite of metabolites (including maltose, allulose, and tyramine) not previously reported in lichen algae, suggesting new candidates for symbiotic signaling. A comparative analysis of Ramalina farinacea and its photobiont, Trebouxia jamesii, revealed a metabolic shift in symbiosis towards sustained arabitol, ribitol, and sucrose accumulation, and away from glucose accumulation, indicating an adaptive carbon-allocation strategy. These findings identify ribitol-centered metabolic rewiring as a pivotal trait for lichenization, provide mechanistic insight into stress resilience and partner specificity, and establish metabolomic profiling as a predictive framework for chemotaxonomy and testing algal-fungal compatibility in symbiotic systems.
No takes yet. Share an insight, caveat, or question.
Pérez-Rodrigo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: